Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $38.60 $44.37 Friday, 10th May 2024 XENE stock ended at $40.54. This is 4.59% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.26% from a day low at $38.60 to a day high of $42.56.
90 days $38.60 $50.99
52 weeks $27.99 $50.99

Historical Xenon Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Aug 30, 2023 $38.73 $39.18 $38.00 $38.88 374 107
Aug 29, 2023 $38.36 $39.05 $38.05 $38.57 297 607
Aug 28, 2023 $38.29 $38.60 $37.93 $38.39 124 315
Aug 25, 2023 $38.22 $38.61 $36.96 $38.05 134 596
Aug 24, 2023 $38.65 $38.94 $37.77 $38.30 240 568
Aug 23, 2023 $38.54 $39.27 $38.32 $38.59 188 084
Aug 22, 2023 $38.07 $38.81 $37.69 $38.39 255 660
Aug 21, 2023 $36.41 $38.26 $36.41 $38.07 590 423
Aug 18, 2023 $34.94 $36.49 $34.94 $36.49 519 858
Aug 17, 2023 $36.57 $36.94 $34.98 $35.07 603 488
Aug 16, 2023 $37.13 $37.56 $36.19 $36.47 388 776
Aug 15, 2023 $37.46 $37.80 $36.94 $37.36 169 157
Aug 14, 2023 $37.68 $38.09 $37.06 $37.54 272 922
Aug 11, 2023 $38.24 $38.63 $37.69 $37.70 233 507
Aug 10, 2023 $36.24 $38.95 $36.19 $38.39 901 515
Aug 09, 2023 $35.37 $36.19 $35.06 $35.45 458 762
Aug 08, 2023 $35.65 $36.18 $35.34 $35.35 345 206
Aug 07, 2023 $37.97 $38.20 $35.51 $35.51 604 224
Aug 04, 2023 $37.69 $38.33 $37.35 $38.17 223 838
Aug 03, 2023 $37.70 $38.23 $36.57 $37.64 345 434
Aug 02, 2023 $37.22 $38.03 $36.87 $37.79 324 502
Aug 01, 2023 $36.92 $38.41 $36.74 $37.38 325 782
Jul 31, 2023 $36.66 $37.33 $36.28 $36.92 155 660
Jul 28, 2023 $36.11 $36.71 $35.55 $36.67 241 023
Jul 27, 2023 $35.85 $36.07 $35.26 $35.83 293 220
Click to get the best stock tips daily for free!

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals. Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment o... XENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT